CVRx, Inc. — Form 8-K
Filed September 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 48/100
What the filing says
CVRx hired John Landry as Chief Financial Officer, effective October 12, 2026, with formal CFO duties commencing after the Q3 2026 10-Q filing (expected early November 2026). Landry succeeds Jared Oasheim and receives $500,000 base salary, 50% bonus target, equity grant of 0.80% of outstanding shares (split 1.5:1 stock options to RSUs), and a one-time sign-on payment for forfeited incentives from his prior employer (Nyxoah SA), conditioned on one-year retention.
Why this rating
Leadership change is standard corporate event. Landry's medtech/public-company finance experience is relevant but company is small-cap ($112M); CFO replacement is material operationally but not financially transformative. No business disruption disclosed.
See more from September 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.